How much funding has Yemaachi Biotechnology raised?

Yemaachi Biotechnology has raised $3.0M in total funding, most recently a Seed round.

Who are Yemaachi Biotechnology's investors?

Yemaachi Biotechnology's investors include V8 Capital Partners, Tencent, Loftyinc Capital, VestedWorld, Y Combinator Continuity Fund.

When was Yemaachi Biotechnology founded?

Yemaachi Biotechnology was founded in 2020.

Where is Yemaachi Biotechnology headquartered?

Yemaachi Biotechnology is headquartered in Accra, Ghana.

What industry is Yemaachi Biotechnology in?

Yemaachi Biotechnology operates in Biotech, Diagnostics, Healthcare, Therapeutics.

How many employees does Yemaachi Biotechnology have?

Yemaachi Biotechnology has 11-50 employees.

Yemaachi Biotechnology

Diversifying precision cancer diagnostics and treatments

Accra, Ghana · Founded 2020 · $3.0M raised

YC S21

Headquarters: Accra
Employees: 11–50
Founded: 2020
Website: yemaachi.com

Total Funding: $3.0M
Last Round: $3.0M SeedMar 2022
Rounds: 1

About

Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.

Summary

Yemaachi Biotechnology is a Biotech company based in Accra, Ghana, founded in 2020. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Mar 2022. Investors include V8 Capital Partners, Tencent and Loftyinc Capital.